Category: Markets
Published: 2026-06-21T17:41:57.000Z
Dorman Products recently restructured its balance sheet by issuing $450 million in senior notes and refinancing its revolving credit facility to $800 million, extending debt maturities and adjusting its funding mix. The stock is currently trading at US$125.66, which is about 21% below the average analyst price target of US$152.25, suggesting it could be 17.5% undervalued. However, its current P/E ratio of 19.7x is above the fair ratio of 18.9x and the peer average of 16.8x, indicating less room for error.
News summary curated and translated by CausifyMarket. Always consult original sources before making any financial decision.